Cost Analysis of Peripherally Inserted Central Catheter in Pediatric Patients

Abstract

This study has demonstrated the costs associated with PICCs. This information may be helpful for healthcare providers to understand PICC related cost in children and resource implications.

Economic evaluation of peripherally inserted central catheter and other venous access devices: A scoping review

“…Results of the literature search and the selection process are presented in Figure 1. Finally, 16 studies 10,13-17, [21][22][23][24][25][26][27][28][29][30] were included.…”

“…The 16 included studies 10,[13][14][15][16][17][21][22][23][24][25][26][27][28][29][30] were published from 1993 to 2018, and most were published in the latest decade. [13][14][15]17,21,24,25,27 The largest number of studies was conducted in the United States (six; 37.5%), 16,23,26,[28][29][30] followed by China (five; 31.25%) 14,17,21,22,27 and Switzerland, Italy, Canada, and Australia (five total). 10,13,15,24,25 There were nine cohort studies, 13,14,16,22,[24][25][26]29,30 five randomized controlled trials (RCTs),…”

“…[13][14][15]17,21,24,25,27 The largest number of studies was conducted in the United States (six; 37.5%), 16,23,26,[28][29][30] followed by China (five; 31.25%) 14,17,21,22,27 and Switzerland, Italy, Canada, and Australia (five total). 10,13,15,24,25 There were nine cohort studies, 13,14,16,22,[24][25][26]29,30 five randomized controlled trials (RCTs), 10,15,17,23,28 and two controlled clinical trials. 21,27 Six of the included studies compared PICCs versus PIVCs for short-term use, 10,17,[21][22][23][24] and most of them concentrated on neonates and pediatric patients (five; 83.3%).…”

“…10,13,15,24,25 There were nine cohort studies, 13,14,16,22,[24][25][26]29,30 five randomized controlled trials (RCTs), 10,15,17,23,28 and two controlled clinical trials. 21,27 Six of the included studies compared PICCs versus PIVCs for short-term use, 10,17,[21][22][23][24] and most of them concentrated on neonates and pediatric patients (five; 83.3%). 17,[21][22][23][24] Seven studies compared PICCs versus CVCs among adult patients, 14,16,[26][27][28][29][30] and most of them focused on patients with chemotherapy requiring medium-or longterm venous access (five; 71.4%).…”

“…8,10 From a health technology assessment point of view, PICCs should be evaluated not only for their safety and effectiveness but also for their economic attributes because economic attributes, such as cost or cost-effectiveness, are also important influencing factors in the selection of VADs. 11 Economic evaluation can provide economicbased evidence for decision-makers, clinical practitioners, and patients to choose an appropriate VAD in clinical practice. Therefore, in recent years, some economic evaluation studies have been performed to compare PICCs with other VADs.…”